C-terminus of MUC16 activates Wnt signaling pathway through its interaction with β-catenin to promote tumorigenesis and metastasis
- PMID: 27167110
- PMCID: PMC5095040
- DOI: 10.18632/oncotarget.9191
C-terminus of MUC16 activates Wnt signaling pathway through its interaction with β-catenin to promote tumorigenesis and metastasis
Abstract
MUC16/CA125 has been identified as a prominent cancer biomarker, especially for epithelial ovarian cancers, in clinical test for over three decades. Due to its huge mass, limited knowledge of MUC16 was acquired previously. By utilizing a well characterized self-made MUC16 monoclonal antibody, we identified the endogenous interaction between a C-terminal fragment of MUC16 (MUC16C) and β-catenin for the first time, and further elucidated that trans-activation domain of β-catenin is required for this interaction. Such interaction could activate the Wnt/β-catenin signaling pathway by facilitating cytosol-nucleus transportation of β-catenin, consequently induce cell proliferation and the migration, eventually lead to tumorigenesis and metastasis in nude mice. Consistently, knockdown of MUC16 significantly weakened the capabilities of cells for proliferation and migration. Based on our discovery, we suggest that MUC16 appears as an attractive target for the development of effective anticancer drugs.
Keywords: C-terminus; MUC16; Wnt signaling; tumorigenesis; β-catenin.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Figures






Similar articles
-
CA125/MUC16 interacts with Src family kinases, and over-expression of its C-terminal fragment in human epithelial cancer cells reduces cell-cell adhesion.Eur J Cell Biol. 2013 Aug-Sep;92(8-9):257-63. doi: 10.1016/j.ejcb.2013.10.005. Epub 2013 Oct 26. Eur J Cell Biol. 2013. PMID: 24246580
-
Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cells.Br J Cancer. 2011 Mar 15;104(6):989-99. doi: 10.1038/bjc.2011.34. Epub 2011 Feb 15. Br J Cancer. 2011. PMID: 21326240 Free PMC article.
-
NLRC5 regulates cell proliferation, migration and invasion in hepatocellular carcinoma by targeting the Wnt/β-catenin signaling pathway.Cancer Lett. 2016 Jun 28;376(1):10-21. doi: 10.1016/j.canlet.2016.03.006. Epub 2016 Mar 11. Cancer Lett. 2016. PMID: 26975630
-
The Wnt/β-catenin pathway in ovarian cancer: a review.Gynecol Oncol. 2013 Dec;131(3):772-9. doi: 10.1016/j.ygyno.2013.09.034. Epub 2013 Oct 11. Gynecol Oncol. 2013. PMID: 24125749 Review.
-
[MUC16: The Novel Target for Tumor Therapy].Zhongguo Fei Ai Za Zhi. 2022 Jul 20;25(7):452-459. doi: 10.3779/j.issn.1009-3419.2022.101.31. Zhongguo Fei Ai Za Zhi. 2022. PMID: 35899441 Free PMC article. Review. Chinese.
Cited by
-
Comprehensive analysis of genomic and immunological profiles in Chinese and Western hepatocellular carcinoma populations.Aging (Albany NY). 2021 Apr 18;13(8):11564-11594. doi: 10.18632/aging.202853. Epub 2021 Apr 18. Aging (Albany NY). 2021. PMID: 33867349 Free PMC article.
-
CAR-T cell immunotherapy for ovarian cancer: hushing the silent killer.Front Immunol. 2023 Dec 7;14:1302307. doi: 10.3389/fimmu.2023.1302307. eCollection 2023. Front Immunol. 2023. PMID: 38146364 Free PMC article. Review.
-
Deciphering genes associated with diffuse large B-cell lymphoma with lymphomatous effusions: A mutational accumulation scoring approach.Biomark Res. 2021 Oct 9;9(1):74. doi: 10.1186/s40364-021-00330-8. Biomark Res. 2021. PMID: 34635181 Free PMC article.
-
Tumor buster - where will the CAR-T cell therapy 'missile' go?Mol Cancer. 2022 Oct 19;21(1):201. doi: 10.1186/s12943-022-01669-8. Mol Cancer. 2022. PMID: 36261831 Free PMC article. Review.
-
Advances Of Chimeric Antigen Receptor T Cell Therapy In Ovarian Cancer.Onco Targets Ther. 2019 Sep 30;12:8015-8022. doi: 10.2147/OTT.S203550. eCollection 2019. Onco Targets Ther. 2019. PMID: 31686857 Free PMC article.
References
-
- Kui Wong N, Easton RL, Panico M, Sutton-Smith M, Morrison JC, Lattanzio FA, Morris HR, Clark GF, Dell A, Patankar MS. Characterization of the oligosaccharides associated with the human ovarian tumor marker CA125. The Journal of biological chemistry. 2003;278:28619–28634. - PubMed
-
- Hollingsworth MA, Swanson BJ. Mucins in cancer: protection and control of the cell surface. Nature reviews Cancer. 2004;4:45–60. - PubMed
-
- Corfield AP. Mucins: a biologically relevant glycan barrier in mucosal protection. Biochimica et biophysica acta. 2015;1850:236–252. - PubMed
-
- Gendler SJ, Burchell JM, Duhig T, Lamport D, White R, Parker M, Taylor-Papadimitriou J. Cloning of partial cDNA encoding differentiation and tumor-associated mucin glycoproteins expressed by human mammary epithelium. Proceedings of the National Academy of Sciences of the United States of America. 1987;84:6060–6064. - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous